HomeAI · summaries
Storia in 5 fonti
23andMe founder buys back genetic testing company in second auction
Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
ft.com
Thermo Fisher aims to sell parts of its diagnostics business for $4bn
Deal would mark latest move by a life sciences group to jettison lower-growth assets
- ·
Meta invests $15bn in Scale AI, doubling start-up’s valuation
The deal values the data-labelling company at $29bn
- ·
cnbc.com
Anne Wojcicki to buy back 23andMe and its data for $305 million
Anne Wojcicki to buy back 23andMe and its data for $305 million
- ·
23andMe founder buys back genetic testing company in second auction
Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals
- ·
techcrunch.com
Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe | TechCrunch
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research Institute, a nonprofit led by the company's…
- ·
theguardian.com
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
Anne Wojcicki made $305m bid for firm, which has lost customers since declaring bankruptcy, with backing of Fortune 500 company
- ·
huffpost.com
23andMe's Founder Wins Bid For Bankrupt DNA Testing Firm
The nonprofit she controls said it would uphold 23andMe's existing privacy policies.